-
Je něco špatně v tomto záznamu ?
Prognostic significance of human papillomavirus (HPV) status and expression of selected markers (HER2/neu, EGFR, VEGF, CD34, p63, p53 and Ki67/MIB-1) on outcome after (chemo-) radiotherapy in patients with squamous cell carcinoma of uterine cervix
M. Vosmik, J. Laco, I. Sirak, M. Beranek, E. Hovorkova, H. Vosmikova, M. Drastikova, M. Hodek, Z. Zoul, K. Odrazka, J. Petera,
Jazyk angličtina Země Nizozemsko
Typ dokumentu časopisecké články, práce podpořená grantem
NLK
ProQuest Central
od 1997-03-01 do 2019-01-31
Medline Complete (EBSCOhost)
od 2014-01-01
Nursing & Allied Health Database (ProQuest)
od 1997-03-01 do 2019-01-31
Health & Medicine (ProQuest)
od 1997-03-01 do 2019-01-31
ROAD: Directory of Open Access Scholarly Resources
od 1995
- MeSH
- antigen Ki-67 genetika MeSH
- antigeny CD34 genetika MeSH
- dospělí MeSH
- erbB receptory genetika MeSH
- exprese genu MeSH
- infekce papilomavirem genetika patologie virologie MeSH
- lidé středního věku MeSH
- lidé MeSH
- membránové proteiny genetika MeSH
- nádorové biomarkery genetika MeSH
- nádorový supresorový protein p53 genetika MeSH
- nádory děložního čípku genetika patologie radioterapie virologie MeSH
- Papillomaviridae izolace a purifikace MeSH
- prognóza MeSH
- receptor erbB-2 genetika MeSH
- retrospektivní studie MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- spinocelulární karcinom genetika patologie radioterapie virologie MeSH
- vaskulární endoteliální růstový faktor A genetika MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
The aim of the retrospective study was to evaluate prognostic significance of human papillomavirus (HPV) status and expression of epidermal growth factor receptor (EGFR), human epidermal growth factor receptor type 2 (HER2/neu), vascular endothelial growth factor (VEGF), CD34 antigen, tumor suppressors p63 and p53, and Ki67/MIB-1 in squamous cell carcinoma of the uterine cervix (SCCC) treated with radiotherapy or chemoradiotherapy. Seventy-two consecutive patients with SCCC, diagnosed and treated with (chemo-) radiotherapy with a curative intent at the University Hospital Hradec Kralove between August 1998 and August 2008, were enrolled in the study. The median follow-up period was 57 months (range 5-152). The tested biological factors were evaluated by polymerase chain reaction (HPV status) and by immunohistochemistry (remaining above mentioned markers) from archival paraffin embedded original diagnostic tumor samples. A statistical significant correlation was observed between low expression of p63 and poor overall survival (p = 0.001), although the complete response probability was influenced with borderline statistical significance (p = 0.05). However, the results could be affected by the statistical error due to the small number of p63 negative patients. HPV positivity and EGFR staining intensity was associated with higher complete response probability (p = 0.038 and p = 0.044, resp.). All other results were not significant. Neither HPV positivity nor EGFR staining intensity were reflected in the overall survival evaluation. In conclusion, the presented study did not confirm any apparently significant association of the suggested markers with prognosis of SCCC in patients treated with (chemo-) radiotherapy.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc15008583
- 003
- CZ-PrNML
- 005
- 20240904092446.0
- 007
- ta
- 008
- 150306s2014 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s12253-013-9674-5 $2 doi
- 035 __
- $a (PubMed)23913252
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Vosmik, Milan $u Department of Oncology and Radiotherapy, University Hospital Hradec Kralove, Sokolská 581, 500 05, Hradec Kralove, Czech Republic, milan.vosmik@fnhk.cz.
- 245 10
- $a Prognostic significance of human papillomavirus (HPV) status and expression of selected markers (HER2/neu, EGFR, VEGF, CD34, p63, p53 and Ki67/MIB-1) on outcome after (chemo-) radiotherapy in patients with squamous cell carcinoma of uterine cervix / $c M. Vosmik, J. Laco, I. Sirak, M. Beranek, E. Hovorkova, H. Vosmikova, M. Drastikova, M. Hodek, Z. Zoul, K. Odrazka, J. Petera,
- 520 9_
- $a The aim of the retrospective study was to evaluate prognostic significance of human papillomavirus (HPV) status and expression of epidermal growth factor receptor (EGFR), human epidermal growth factor receptor type 2 (HER2/neu), vascular endothelial growth factor (VEGF), CD34 antigen, tumor suppressors p63 and p53, and Ki67/MIB-1 in squamous cell carcinoma of the uterine cervix (SCCC) treated with radiotherapy or chemoradiotherapy. Seventy-two consecutive patients with SCCC, diagnosed and treated with (chemo-) radiotherapy with a curative intent at the University Hospital Hradec Kralove between August 1998 and August 2008, were enrolled in the study. The median follow-up period was 57 months (range 5-152). The tested biological factors were evaluated by polymerase chain reaction (HPV status) and by immunohistochemistry (remaining above mentioned markers) from archival paraffin embedded original diagnostic tumor samples. A statistical significant correlation was observed between low expression of p63 and poor overall survival (p = 0.001), although the complete response probability was influenced with borderline statistical significance (p = 0.05). However, the results could be affected by the statistical error due to the small number of p63 negative patients. HPV positivity and EGFR staining intensity was associated with higher complete response probability (p = 0.038 and p = 0.044, resp.). All other results were not significant. Neither HPV positivity nor EGFR staining intensity were reflected in the overall survival evaluation. In conclusion, the presented study did not confirm any apparently significant association of the suggested markers with prognosis of SCCC in patients treated with (chemo-) radiotherapy.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a senioři nad 80 let $7 D000369
- 650 _2
- $a antigeny CD34 $x genetika $7 D018952
- 650 _2
- $a spinocelulární karcinom $x genetika $x patologie $x radioterapie $x virologie $7 D002294
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a exprese genu $7 D015870
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a antigen Ki-67 $x genetika $7 D019394
- 650 _2
- $a membránové proteiny $x genetika $7 D008565
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a Papillomaviridae $x izolace a purifikace $7 D027383
- 650 _2
- $a infekce papilomavirem $x genetika $x patologie $x virologie $7 D030361
- 650 _2
- $a prognóza $7 D011379
- 650 _2
- $a erbB receptory $x genetika $7 D066246
- 650 _2
- $a receptor erbB-2 $x genetika $7 D018719
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 _2
- $a nádorové biomarkery $x genetika $7 D014408
- 650 _2
- $a nádorový supresorový protein p53 $x genetika $7 D016159
- 650 _2
- $a nádory děložního čípku $x genetika $x patologie $x radioterapie $x virologie $7 D002583
- 650 _2
- $a vaskulární endoteliální růstový faktor A $x genetika $7 D042461
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Laco, Jan
- 700 1_
- $a Sirak, Igor
- 700 1_
- $a Beranek, Martin
- 700 1_
- $a Hovorkova, Eva
- 700 1_
- $a Vosmikova, Hana
- 700 1_
- $a Drastíková, Monika $7 xx0321911
- 700 1_
- $a Hodek, Miroslav
- 700 1_
- $a Zoul, Zdenek
- 700 1_
- $a Odrazka, Karel
- 700 1_
- $a Petera, Jiri
- 773 0_
- $w MED00180530 $t Pathology oncology research $x 1532-2807 $g Roč. 20, č. 1 (2014), s. 131-7
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/23913252 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20150306 $b ABA008
- 991 __
- $a 20240904092442 $b ABA008
- 999 __
- $a ok $b bmc $g 1065856 $s 891383
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2014 $b 20 $c 1 $d 131-7 $i 1532-2807 $m Pathology oncology research $n Pathol Oncol Res $x MED00180530
- LZP __
- $a Pubmed-20150306